In this episode, Sarah Ussery joins to discuss her career journey and the distinctions between working in big pharma versus small biotech companies. Sarah provides an overview of both environments, highlighting the evolution of the MSL role and the responsibilities unique to each. She explores growth opportunities and the job market for both sectors, while addressing the challenges and cultural differences encountered in each setting. The conversation includes advice for MSLs navigating their careers in 2024, with insights on resume building and choosing between large pharma and small biotech. The episode concludes with closing remarks and a call to action.
My guest today is Sarah Ussery, Medical Affairs Leader who discusses the differences in MSL function between large pharma and small biotech.
Sarah shares….
👉 What is considered Large Pharma VS Small Biotech
👉 How do MSL responsibilities differ by size of company
👉 How are MSLs evaluated differently by different companies
👉 How do the frustrations differ for MSLs in different size companies
👉 What are the cultural differences between different size companies
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
iNIZIO
Forbes Books Press Release Official
Sarah A. Weiss, MD, and Harriet Kluger, MD